TC
WINT

TFS Capital’s Windtree Therapeutics Inc WINT Stock Holding History

TFS Capital’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,402
Closed -$62K – 1284
2014
Q3 		$62K Sell
2,402
-3,781
-61% -$91.3K 0.01% 995
2014
Q2 		$154K Sell
6,183
-17,900
-74% -$458K 0.01% 999
2014
Q1 		$725K Sell
24,083
-19,765
-45% -$665K 0.05% 584
2013
Q4 		$1.38M Buy
43,848
+38,318
+693% +$1.2M 0.07% 441
2013
Q3 		$152K Buy
5,530
+3,306
+149% +$80.1K 0.01% 1319
2013
Q2 		$47K Buy
+2,224
New +$54.8K ﹤0.01% 1463

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

TFS Capital's WINT Position: Q4 2014 in Review

TFS Capital sold out of Windtree Therapeutics Inc (WINT) in Q4 2014, closing a stake of 2,402 shares — an estimated $62K sold.

TFS Capital first reported a position in WINT in Q2 2013 and held it in 6 quarters. The position peaked at $1.38M in Q4 2013. 56 funds tracked by Wall St. Rank hold WINT as of Q4 2014.

  • TFS Capital reported no remaining Windtree Therapeutics Inc position as of Q4 2014 after selling out during the quarter.
  • TFS Capital sold 2,402 Windtree Therapeutics Inc shares in Q4 2014, an estimated $62K.
  • TFS Capital first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 6 quarters.
  • TFS Capital's Windtree Therapeutics Inc position peaked at $1.38M in Q4 2013.
  • 56 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2014.

Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.